Differential Effects ofl-Dopa and Apomorphine on Glucagon Secretion in Man: Evidence Against Central Dopaminergic Stimulation of Glucagon
- 1 December 1977
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 45 (6) , 1154-1158
- https://doi.org/10.1210/jcem-45-6-1154
Abstract
In 6 normal subjects, l-dopa (500 mg PO) and apomorphine (0.6 mg sc) increased circulating growth hormone and suppressed prolactin levels in a parallel and quantitatively similar fashion, but only l-dopa induced a rise in plasma glucagon, glucose, and insulin levels. The failure of apomorphine to affect glucagon secretion, despite a substantial effect on growth hormone and prolactin, was also observed in insulin-dependent diabetics known to exhibit A-cell hyperresponsiveness to various stimuli. In view of the highly dissimilar molecular and pharmacologic characteristics of l-dopa and apomorphine, these data do not exclude a local dopaminergic effect of l-dopa at the pancreatic level, but strongly militate against a central dopaminergic pathway for glucagon stimulation.Keywords
This publication has 6 references indexed in Scilit:
- Effects of apomorphine and of pimozide on renin secretion in the anaesthetized dogEuropean Journal of Pharmacology, 1976
- A study of muscarinic receptor heterogeneity with weak antagonistsEuropean Journal of Pharmacology, 1976
- Glucose suppression of serum growth hormone in the diagnosis of acromegalyJAMA, 1967
- Mode of action of apomorphine and dexamphetamine on gnawing compulsion in ratsPsychopharmacology, 1967
- AN IMMUNOCHEMICAL ASSAY OF TOTAL EXTRACTABLE INSULIN IN MAN *Journal of Clinical Investigation, 1960
- THE METABOLISM OF 3,4-DIHYDROXYPHENYLALANINEJournal of Biological Chemistry, 1957